Two Sigma Securities’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28,390	Closed	-$27.5K	–	1640
2025 Q1	$27.5K	Buy	28,390 +6,028	+27%	+$5.85K	﹤0.01%	1044
2024 Q4	$26.2K	Buy	+22,362	New	+$26.2K	﹤0.01%	1082
2017 Q3	–	Sell	-319	Closed	-$9K	–	947
2017 Q2	$9K	Buy	+319	New	+$9K	﹤0.01%	811